COMPANY GENERAL SECURITY AGREEMENTCompany General Security Agreement • January 31st, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 31st, 2006 Company Industry JurisdictionThis Company General Security Agreement (the “Agreement”) is dated as of January 31, 2006 by and among Acura Pharmaceuticals, Inc., a New York corporation with its principal place of business at 616 N. North Court, Palatine, Illinois, 60067 (“Debtor”), and Galen Partners III, L.P., a Delaware limited partnership with its principal place of business at 610 Fifth Avenue, Fifth Floor, New York, New York, 10020, acting in its capacity as agent for the Lenders, as defined below (the “Agent”), for the benefit of the Lenders.
COMPANY GENERAL SECURITY AGREEMENTCompany General Security Agreement • November 10th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2005 Company Industry JurisdictionThis Company General Security Agreement (the “Agreement”) is dated as of November 9, 2005 by and among Acura Pharmaceuticals, Inc., a New York corporation with its principal place of business at 616 N. North Court, Palatine, Illinois, 60067 (“Debtor”), and Galen Partners III, L.P., a Delaware limited partnership with its principal place of business at 610 Fifth Avenue, Fifth Floor, New York, New York, 10020, acting in its capacity as agent for the Lenders, as defined below (the “Agent”), for the benefit of the Lenders.
COMPANY GENERAL SECURITY AGREEMENTCompany General Security Agreement • September 16th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2005 Company Industry JurisdictionThis Company General Security Agreement (the “Agreement”) is dated as of September 16, 2005 by and among Acura Pharmaceuticals, Inc., a New York corporation with its principal place of business at 616 N. North Court, Palatine, Illinois, 60067 (“Debtor”), and Galen Partners III, L.P., a Delaware limited partnership with its principal place of business at 610 Fifth Avenue, Fifth Floor, New York, New York, 10020, acting in its capacity as agent for the Lenders, as defined below (the “Agent”), for the benefit of the Lenders.
COMPANY GENERAL SECURITY AGREEMENTCompany General Security Agreement • June 23rd, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 23rd, 2005 Company Industry JurisdictionThis Company General Security Agreement (the “Agreement”) is dated as of June 22, 2005 by and among Acura Pharmaceuticals, Inc., a New York corporation with its principal place of business at 616 N. North Court, Palatine, Illinois, 60067 (“Debtor”), and Galen Partners III, L.P., a Delaware limited partnership with its principal place of business at 610 Fifth Avenue, Fifth Floor, New York, New York, 10020, acting in its capacity as agent for the Lenders, as defined below (the “Agent”), for the benefit of the Lenders.